Vitruvias Therapeutics Inc.
Vitruvias Therapeutics Inc. faces scrutiny as FDA issues highest-risk alert for its thyroid pills, highlighting safety concerns and regulatory challenges.
![FDA Issues Highest-Risk Alert for Thyroid Pills in the U.S.]()
FDA Issues Highest-Risk Alert for Thyroid Pills in the U.S.
Published on 9/26/2026
